What is Decide?
Established in 2015, DECIDE operates as a specialized consulting company, providing critical services in health technology assessment, health economics, and the evaluation of health care programs. The firm supports decision-makers across the health care and welfare service sectors, catering to drug companies, non-profit organizations, and government agencies. DECIDE's core offerings include both qualitative and quantitative assessments, with a strong emphasis on health economic projects such as cost analyses and real-world evidence studies. Their strategic collaborations with entities like COWI and the Swedish Institute for Health Economics further bolster their capabilities in delivering comprehensive insights.
How much funding has Decide raised?
Decide has raised a total of $16.5M across 3 funding rounds:
Series A
$2.5M
Series B
$6M
Series C
$8M
Series A (2009): $2.5M with participation from Madrona Venture Group
Series B (2011): $6M led by Maveron LLC and Madrona Venture Group
Series C (2013): $8M supported by Maveron and Madrona Venture Group
Key Investors in Decide
Maveron
Maveron is a consumer-focused venture capital firm that invests in early-stage companies transforming consumer experiences. Their commitment to inclusive growth and B Corp certification highlights a focus on sustainable impact alongside financial returns.
Madrona Venture Group
Madrona Venture Group is a venture capital firm established in 1995, with a broad investment focus across consumer internet, commercial software, and services, supporting technology-driven companies.
Maveron LLC
Maveron LLC, a consumer-only venture capital firm, partners with entrepreneurs to innovate consumer experiences and industries, emphasizing human behavior and technological disruption.
What's next for Decide?
The substantial enterprise-level funding and recent strategic investment signal a pivotal phase for Decide. This capital infusion is expected to fuel further expansion of its specialized consulting services, potentially enabling deeper penetration into existing markets and the exploration of new service verticals within health technology and economics. The company's focus on evidence-based assessments positions it for continued growth as healthcare systems globally seek to optimize resource allocation and demonstrate value. Future strategic initiatives may involve enhancing data analytics capabilities, expanding its partner network, and potentially developing proprietary assessment tools to solidify its market leadership.
See full Decide company page
